The recent results of a clinical trial for an oral obesity drug developed by Viking Therapeutics have generated significant interest. The drug has shown promise in early-phase trials, capturing the attention of Wall Street analysts and investors alike. The study results, revealed at a medical
Recent developments in the pharmaceutical industry underscore the volatile nature of advancements and market dynamics affecting prominent companies. The latest updates reveal a mix of struggles and achievements that highlight how pharmaceutical giants are navigating the complexities of drug
The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is experiencing a transformative period marked by the recent appointment of Michelle Tarver as its new director. Tarver, a clinical ophthalmologist with extensive experience within the FDA, steps into her l
MilliporeSigma has announced a substantial $76 million investment to expand its Bioconjugation Center of Excellence in St. Louis, Missouri, aiming to triple its current capacity for Antibody-Drug Conjugates (ADCs). This significant expansion will encompass upgrading 34,000 square feet of existing
Jubilant Radiopharma and Simplified Imaging Solutions (SIS) have announced a strategic partnership aimed at enhancing nuclear medicine services for healthcare providers across the United States. This collaboration is set to create a comprehensive, full-service solution designed to simplify nuclear
In a significant move that aims to revolutionize its IT operations, Alnylam Pharmaceuticals Inc. has entered into a strategic collaboration with Cognizant. This partnership is designed to both transform and scale Alnylam's global infrastructure, cloud, security, platforms, applications, and
In the fast-evolving world of biotechnology, the integration of AI in cell culture monitoring and analysis has emerged as a game-changing advancement. Among the pioneers in this domain is BioTech Innovations, a corporation renowned for its groundbreaking work, which employs AI to revolutionize cell
Global biopharma giant GSK (GlaxoSmithKline) has made a monumental decision to significantly expand its facility in Marietta, Lancaster County, Pennsylvania. The pharmaceutical company is committing up to $800 million to enhance its research, development, and manufacturing capabilities. This
Eurofins CDMO Alphora Inc., a contract development and manufacturing organization (CDMO), has recently taken a significant leap in its operational capabilities. The company has unveiled a new Active Pharmaceutical Ingredient (API) manufacturing facility in Mississauga, Canada. This expansion
Clinical trials have long faced significant challenges in enrolling and retaining participants, a problem exacerbated by logistical and engagement difficulties inherent in the clinical trial process. Recent data highlights that up to one-third of trial participants drop out before the studies are
